Evidence map›Paper›PMID 33497412›Full record

ArticlePloS one2021

Adipocyte-induced transdifferentiation of osteoblasts and its potential role in age-related bone loss.

Aline Clabaut, Céline Grare, Gaëlle Rolland-Valognes, Jean-Guillaume Letarouilly, Chantal Bourrier, Thomas L Andersen, Tanja Sikjær, Lars Rejnmark, Charlotte Ejersted, Philippe Pastoureau and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Bone marrow adipocytes: key players in vascular niches, aging, and disease.Frontiers in cell and developmental biology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Effects ofFrontiers in bioengineering and biotechnology · 2022
    Article
  17. Report From the 6Frontiers in endocrinology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Aline ClabautMarrow Adiposity and Bone Lab, MABLab ULR4490, Univ. Littoral Côte d'Opale, Boulogne-sur-Mer, France.ORCID 0000-0003-1869-3338
Céline GrareMarrow Adiposity and Bone Lab, MABLab ULR4490, Univ. Littoral Côte d'Opale, Boulogne-sur-Mer, France.
Gaëlle Rolland-ValognesCentExBiotechnology, Servier Research Institute, Croissy-sur-Seine, France.
Jean-Guillaume LetarouillyMarrow Adiposity and Bone Lab, MABLab ULR4490, Univ. Littoral Côte d'Opale, Boulogne-sur-Mer, France.
Chantal BourrierCentExBiotechnology, Servier Research Institute, Croissy-sur-Seine, France.
Thomas L AndersenDepartment of Pathology, Odense University Hospital, Odense, Denmark.ORCID 0000-0002-6981-7276
Tanja SikjærDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Lars RejnmarkDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-2152-4247
Charlotte EjerstedDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.
Philippe PastoureauCTI Immuno-Inflammatory Disease, Servier Research Institute, Croissy-sur-Seine, France.
Pierre HardouinMarrow Adiposity and Bone Lab, MABLab ULR4490, Univ. Littoral Côte d'Opale, Boulogne-sur-Mer, France.
Massimo SabatiniCTI Immuno-Inflammatory Disease, Servier Research Institute, Croissy-sur-Seine, France.
Odile BrouxMarrow Adiposity and Bone Lab, MABLab ULR4490, Univ. Littoral Côte d'Opale, Boulogne-sur-Mer, France.
Université de Lille · FRServier (France) · FRAarhus University Hospital · DKOdense University Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our preliminary findings have lead us to propose bone marrow adipocyte secretions as new contributors to bone loss. Indeed, using a coculture model based on human bone marrow stromal cells, we previously showed that soluble factors secreted by adipocytes induced the conversion of osteoblasts towards an adipocyte-like phenotype. In this study, microarray gene expression profiling showed profound transcriptomic changes in osteoblasts following coculture and confirmed the enrichment of the adipocyte gene signature. Double immunofluorescence microscopic analyses demonstrated the coexpression of adipogenic and osteoblastic specific markers in individual cells, providing evidence for a transdifferentiation event. At the molecular level, this conversion was associated with upregulated expression levels of reprogramming genes and a decrease in the DNA methylation level. In line with these in vitro results, preliminary immunohistochemical analysis of bone sections revealed adipogenic marker expression in osteoblasts from elderly subjects. Altogether, these data suggest that osteoblast transdifferentiation could contribute to decreased bone mass upon ageing.

Indexed as

AdipocytesCells, CulturedCell TransdifferentiationCoculture TechniquesGene Expression ProfilingHumansOsteoblastsOsteoporosisTranscriptome

Identifiers

PMID33497412
PMCPMC7837466
OpenAlexW3125949857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.